Update on the role of spinal cord TRPV1 receptors in pain modulation

Physiological Research

Volumn 63, Issue SUPPL., 2014, Pages

  Spicarova, D ^a   Nerandzic, V ^a   Palecek, J ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Capsaicin; Hyperalgesia; Spinal cord; Trpv1

Indexed keywords

ENDOCANNABINOID; TRPV1 RECEPTOR; VANILLOID RECEPTOR;

ANIMAL; HUMAN; METABOLISM; NOCICEPTION; PAIN; PATHOPHYSIOLOGY; REVIEW; SPINAL CORD;

ANIMALS; ENDOCANNABINOIDS; HUMANS; PAIN; PAIN PERCEPTION; SPINAL CORD; TRPV CATION CHANNELS;

EID: 84897589790     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. AHLUWALIA J, YAQOOB M, URBAN L, BEVAN S, NAGY I. Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J Neurochem 84. 585-591, 2003.
2. AKOPIAN AN, RUPAREL NB, JESKE NA, PATWARDHAN A, HARGREAVES KM. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. Trends Pharmacol Sci 30. 79-84, 2009.
3. ALKAITIS MS, SOLORZANO C, LANDRY RP, PIOMELLI D, DELEO JA, ROMERO-SANDOVAL EA. Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain. PLoS One 5. e10891, 2010.
4. ANAND P, BLEY K. Topical capsaicin for pain management. therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8 % patch. Br J Anaesth 107. 490-502, 2011.
5. BACCEI ML, BARDONI R, FITZGERALD M. Development of nociceptive synaptic inputs to the neonatal rat dorsal horn. glutamate release by capsaicin and menthol. J Physiol 549. 231-242, 2003.
6. BENCIVINNI I, FERRINI F, SALIO C, BELTRAMO M, MERIGHI A. The somatostatin analogue octreotide inhibits capsaicin-mediated activation of nociceptive primary afferent fibres in spinal cord lamina II (substantia gelatinosa). Eur J Pain 15. 591-599, 2011.
7. BISHNOI M, BOSGRAAF CA, ABOOJ M, ZHONG L, PREMKUMAR LS. Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats. role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators. Mol Pain 7. 52, 2011.
8. BISHNOI M, BOSGRAAF CA, PREMKUMAR LS. Preservation of acute pain and efferent functions following intrathecal resiniferatoxin-induced analgesia in rats. J Pain 12. 991-1003, 2011.
9. BORROTO-ESCUELA DO, ROMERO-FERNANDEZ W, RIVERA A, VAN CRAENENBROECK K, TARAKANOV AO, AGNATI LF, FUXE K. On the g-protein-coupled receptor heteromers and their allosteric receptorreceptor interactions in the central nervous system. focus on their role in pain modulation. Evid Based Complement Alternat Med 2013. 563716, 2013.
10. BUCZYNSKI MW, SVENSSON CI, DUMLAO DS, FITZSIMMONS BL, SHIM JH, SCHERBART TJ, JACOBSEN FE, HUA XY, YAKSH TL, DENNIS EA. Inflammatory hyperalgesia induces essential bioactive lipid production in the spinal cord. J Neurochem 114. 981-993, 2010.
11. CATERINA MJ, SCHUMACHER MA, TOMINAGA M, ROSEN TA, LEVINE JD, JULIUS D. The capsaicin receptor. a heat-activated ion channel in the pain pathway. Nature 389. 816-824, 1997.
12. CATERINA MJ, LEFFLER A, MALMBERG AB, MARTIN WJ, TRAFTON J, PETERSEN-ZEITZ KR, KOLTZENBURG M, BASBAUM AI, JULIUS D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288. 306-313, 2000.
13. CAVANAUGH DJ, LEE H, LO L, SHIELDS SD, ZYLKA MJ, BASBAUM AI, ANDERSON DJ. Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli. Proc Natl Acad Sci USA 106. 9075-9080, 2009.
14. CAVANAUGH DJ, CHESLER AT, BRAZ JM, SHAH NM, JULIUS D, BASBAUM AI. Restriction of transient receptor potential vanilloid-1 to the peptidergic subset of primary afferent neurons follows its developmental downregulation in nonpeptidergic neurons. J Neurosci 31. 10119-10127, 2011.
15. CAVANAUGH DJ, CHESLER AT, JACKSON AC, SIGAL YM, YAMANAKA H, GRANT R, O'DONNELL D, NICOLL RA, SHAH NM, JULIUS D, BASBAUM AI. Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci 31. 5067-5077, 2011.
16. CHEN Y, WILLCOCKSON HH, VALTSCHANOFF JG. Influence of the vanilloid receptor TRPV1 on the activation of spinal cord glia in mouse models of pain. Exp Neurol 220. 383-390, 2009.
17. CHUANG HH, PRESCOTT ED, KONG H, SHIELDS S, JORDT SE, BASBAUM AI, CHAO MV, JULIUS D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411. 957-962, 2001.
18. CONSTANTIN CE, MAIR N, SAILER CA, ANDRATSCH M, XU ZZ, BLUMER MJ, SCHERBAKOV N, DAVIS JB, BLUETHMANN H, JI RR, KRESS M. Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J Neurosci 28. 5072-5081, 2008.
19. DE PETROCELLIS L, DI MARZO V. Role of endocannabinoids and endovanilloids in Ca2+ signalling. Cell Calcium 45. 611-624, 2009.
20. DI MARZO V. Endocannabinoids. synthesis and degradation. Rev Physiol Biochem Pharmacol 160. 1-24, 2008.
21. DI MARZO V, CRISTINO L. Why endocannabinoids are not all alike. Nat Neurosci 11. 124-126, 2008.
22. DI MARZO V, DE PETROCELLIS L. Endocannabinoids as regulators of transient receptor potential (TRP) channels. A further opportunity to develop new endocannabinoid-based therapeutic drugs. Curr Med Chem 17. 1430-1449, 2010.
23. DI MARZO V, DE PETROCELLIS L. Why do cannabinoid receptors have more than one endogenous ligand? Philos Trans R Soc Lond B Biol Sci 367. 3216-3228, 2012.
24. FERRINI F, SALIO C, LOSSI L, GAMBINO G, MERIGHI A. Modulation of inhibitory neurotransmission by the vanilloid receptor type 1 (TRPV1) in organotypically cultured mouse substantia gelatinosa neurons. Pain 150. 128-140, 2010.
25. FISCHER MJ, BTESH J, MCNAUGHTON PA. Disrupting sensitization of transient receptor potential vanilloid subtype 1 inhibits inflammatory hyperalgesia. J Neurosci 33. 7407-7414, 2013.
26. GREGUS AM, DOOLEN S, DUMLAO DS, BUCZYNSKI MW, TAKASUSUKI T, FITZSIMMONS BL, HUA XY, TAYLOR BK, DENNIS EA, YAKSH TL. Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc Natl Acad Sci USA 109. 6721-6726, 2012.
27. GUINDON J, LAI Y, TAKACS SM, BRADSHAW HB, HOHMANN AG. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy. effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. Pharmacol Res 67. 94-109, 2013.
28. IADAROLA MJ, MANNES AJ. The vanilloid agonist resiniferatoxin for interventional-based pain control. Curr Top Med Chem 11. 2171-2179, 2011.
29. JARA-OSEGUERA A, SIMON SA, ROSENBAUM T. TRPV1. on the road to pain relief. Curr Mol Pharmacol 1. 255-269, 2008.
30. JEFFRY JA, YU SQ, SIKAND P, PARIHAR A, EVANS MS, PREMKUMAR LS. Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia. PLoS One 4. e7021, 2009.
31. JI RR, XU ZZ, STRICHARTZ G, SERHAN CN. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 34. 599-609, 2011.
32. JUNG J, HWANG SW, KWAK J, LEE SY, KANG CJ, KIM WB, KIM D, OH U. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 19. 529-538, 1999.
33. KASZAS K, KELLER JM, CODDOU C, MISHRA SK, HOON MA, STOJILKOVIC S, JACOBSON KA, IADAROLA MJ. Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH. J Pharmacol Exp Ther 340. 152-160, 2012.
34. KIM H, CUI L, KIM J, KIM SJ. Transient receptor potential vanilloid type 1 receptor regulates glutamatergic synaptic inputs to the spinothalamic tract neurons of the spinal cord deep dorsal horn. Neuroscience 160. 508-516, 2009.
35. KIM YH, PARK CK, BACK SK, LEE CJ, HWANG SJ, BAE YC, NA HS, KIM JS, JUNG SJ, OH SB. Membranedelimited coupling of TRPV1 and mGluR5 on presynaptic terminals of nociceptive neurons. J Neurosci 29. 10000-10009, 2009.
36. KIM YH, BACK SK, DAVIES AJ, JEONG H, JO HJ, CHUNG G, NA HS, BAE YC, KIM SJ, KIM JS, JUNG SJ, OH SB. TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord. Neuron 74. 640-647, 2012.
37. KISSIN I, SZALLASI A. Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials. Curr Top Med Chem 11. 2159-2170, 2011.
38. LAPPIN SC, RANDALL AD, GUNTHORPE MJ, MORISSET V. TRPV1 antagonist, SB-366791, inhibits glutamatergic synaptic transmission in rat spinal dorsal horn following peripheral inflammation. Eur J Pharmacol 540. 73-81, 2006.
39. LEBOVITZ EE, KELLER JM, KOMINSKY H, KASZAS K, MARIC D, IADAROLA MJ. Positive allosteric modulation of TRPV1 as a novel analgesic mechanism. Mol Pain 8. 70, 2012.
40. MACCARRONE M, ROSSI S, BARI M, DE CHIARA V, FEZZA F, MUSELLA A, GASPERI V, PROSPERETTI C, BERNARDI G, FINAZZI-AGRO A, CRAVATT BF, CENTONZE D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 11. 152-159, 2008.
41. MARCHAND F, PERRETTI M, MCMAHON SB. Role of the immune system in chronic pain. Nat Rev Neurosci 6. 521-532, 2005.
42. MATTA JA, AHERN GP. TRPV1 and synaptic transmission. Curr Pharm Biotechnol 12. 95-101, 2011.
43. MILLNS PJ, CHIMENTI M, ALI N, RYLAND E, DE LAGO E, FERNANDEZ-RUIZ J, CHAPMAN V, KENDALL DA. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors. Eur J Neurosci 24. 3489-3495, 2006.
44. MISHRA SK, HOON MA. Ablation of TrpV1 neurons reveals their selective role in thermal pain sensation. Mol Cell Neurosci 43. 157-163, 2010.
45. MITCHELL K, BATES BD, KELLER JM, LOPEZ M, SCHOLL L, NAVARRO J, MADIAN N, HASPEL G, NEMENOV MI, IADAROLA MJ. Ablation of rat TRPV1-expressing Adelta/C-fibers with resiniferatoxin. analysis of withdrawal behaviors, recovery of function and molecular correlates. Mol Pain 6. 94, 2010.
46. MOGG AJ, MILL CE, FOLLY EA, BEATTIE RE, BLANCO MJ, BECK JP, BROAD LM. Altered pharmacology of native rodent spinal cord TRPV1 after phosphorylation. Br J Pharmacol 168. 1015-1029, 2013.
47. MORENO-MARTET M, MESTRE L, LORIA F, GUAZA C, FERNANDEZ-RUIZ J, DE LAGO E. Identification of receptors and enzymes for endocannabinoids in NSC-34 cells. relevance for in vitro studies with cannabinoids in motor neuron diseases. Neurosci Lett 508. 67-72, 2012.
48. NAGY B, FEDONIDIS C, PHOTIOU A, WAHBA J, PAULE CC, MA D, BULUWELA L, NAGY I. Capsaicinsensitive primary sensory neurons in the mouse express N-Acyl phosphatidylethanolamine phospholipase D. Neuroscience 161. 572-577, 2009.
49. NISHIO N, TANIGUCHI W, SUGIMURA YK, TAKIGUCHI N, YAMANAKA M, KIYOYUKI Y, YAMADA H, MIYAZAKI N, YOSHIDA M, NAKATSUKA T. Reactive oxygen species enhance excitatory synaptic transmission in rat spinal dorsal horn neurons by activating TRPA1 and TRPV1 channels. Neuroscience 247C. 201-212, 2013.
50. OKAMOTO Y, MORISHITA J, TSUBOI K, TONAI T, UEDA N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279. 5298-5305, 2004.
51. OKINE BN, NORRIS LM, WOODHAMS S, BURSTON J, PATEL A, ALEXANDER SP, BARRETT DA, KENDALL DA, BENNETT AJ, CHAPMAN V. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour. evidence for plastic changes in the endocannabinoid system. Br J Pharmacol 167. 627-640, 2012.
52. OLD EA, MALCANGIO M. Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states. Curr Opin Pharmacol 12. 67-73, 2012.
53. PABBIDI RM, YU SQ, PENG S, KHARDORI R, PAUZA ME, PREMKUMAR LS. Influence of TRPV1 on diabetesinduced alterations in thermal pain sensitivity. Mol Pain 4. 9, 2008.
54. PALAZZO E, LUONGO L, DE NOVELLIS V, BERRINO L, ROSSI F, MAIONE S. Moving towards supraspinal TRPV1 receptors for chronic pain relief. Mol Pain 6. 66, 2010.
55. PARK CK, LU N, XU ZZ, LIU T, SERHAN CN, JI RR. Resolving TRPV1- and TNF-alpha-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci 31. 15072-15085, 2011.
56. PARK CK, XU ZZ, LIU T, LU N, SERHAN CN, JI RR. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice. distinct roles of resolvin D1, D2, and E1. J Neurosci 31. 18433-18438, 2011.
57. PATWARDHAN AM, SCOTLAND PE, AKOPIAN AN, HARGREAVES KM. Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc Natl Acad Sci USA 106. 18820-18824, 2009.
58. PERTWEE RG. Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6. 635-664, 1999.
59. RICHARDSON JD, AANONSEN L, HARGREAVES KM. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J Neurosci 18. 451-457, 1998.
60. ROSS RA. Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol 140. 790-801, 2003.
61. SERHAN CN, HONG S, GRONERT K, COLGAN SP, DEVCHAND PR, MIRICK G, MOUSSIGNAC RL. Resolvins. a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196. 1025-1037, 2002.
62. SHIRE D, CALANDRA B, DELPECH M, DUMONT X, KAGHAD M, LE FUR G, CAPUT D, FERRARA P. Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J Biol Chem 271. 6941-6946, 1996.
63. SCHILLING T, EDER C. Importance of the non-selective cation channel TRPV1 for microglial reactive oxygen species generation. J Neuroimmunol 216. 118-121, 2009.
64. SCHOMBERG D, OLSON JK. Immune responses of microglia in the spinal cord. contribution to pain states. Exp Neurol 234. 262-270, 2012.
65. SINGH TAHIM A, SANTHA P, NAGY I. Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons. Neuroscience 136. 539-548, 2005.
66. SPICAROVA D, PALECEK J. The role of spinal cord vanilloid (TRPV1) receptors in pain modulation. Physiol Res 57 (Suppl 3). S69-S77, 2008.
67. SPICAROVA D, PALECEK J. The role of the TRPV1 endogenous agonist N-Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level. J Neurophysiol 102. 234-243, 2009.
68. SPICAROVA D, PALECEK J. Tumor necrosis factor alpha sensitizes spinal cord TRPV1 receptors to the endogenous agonist N-oleoyldopamine. J Neuroinflammation 7. 49, 2010.
69. SPICAROVA D, NERANDZIC V, PALECEK J. Modulation of spinal cord synaptic activity by tumor necrosis factor alpha in a model of peripheral neuropathy. J Neuroinflammation 8. 177, 2011.
70. STAROWICZ K, MAKUCH W, OSIKOWICZ M, PISCITELLI F, PETROSINO S, DI MARZO V, PRZEWLOCKA B. Spinal anandamide produces analgesia in neuropathic rats. possible CB(1)- and TRPV1-mediated mechanisms. Neuropharmacology 62. 1746-1755, 2012.
71. STAROWICZ K, PRZEWLOCKA B. Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system. Philos Trans R Soc Lond B Biol Sci 367. 3286-3299, 2012.
72. TALBOT S, DIAS JP, LAHJOUJI K, BOGO MR, CAMPOS MM, GAUDREAU P, COUTURE R. Activation of TRPV1 by capsaicin induces functional kinin B(1) receptor in rat spinal cord microglia. J Neuroinflammation 9. 16, 2012.
73. VAN DER STELT M, TREVISANI M, VELLANI V, DE PETROCELLIS L, SCHIANO MORIELLO A, CAMPI B, MCNAUGHTON P, GEPPETTI P, DI MARZO V. Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels. EMBO J 24. 3026-3037, 2005.
74. VARGA A, JENES A, MARCZYLO TH, SOUSA-VALENTE J, CHEN J, AUSTIN J, SELVARAJAH S, PISCITELLI F, ANDREOU AP, TAYLOR AH, KYLE F, YAQOOB M, BRAIN S, WHITE JP, CSERNOCH L, DI MARZO V, BULUWELA L, NAGY I. Anandamide produced by Ca-insensitive enzymes induces excitation in primary sensory neurons. Pflugers Arch. 2013 (Oct. 10, Epub).
75. VELLANI V, PETROSINO S, DE PETROCELLIS L, VALENTI M, PRANDINI M, MAGHERINI PC, MCNAUGHTON PA, DI MARZO V. Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. Neuropharmacology 55. 1274-1279, 2008.
76. WATABIKI T, KISO T, TSUKAMOTO M, AOKI T, MATSUOKA N. Intrathecal administration of AS1928370, a transient receptor potential vanilloid 1 antagonist, attenuates mechanical allodynia in a mouse model of neuropathic pain. Biol Pharm Bull 34. 1105-1108, 2011.
77. WU Z, YANG Q, CROOK RJ, O'NEIL RG, WALTERS ET. TRPV1 channels make major contributions to behavioral hypersensitivity and spontaneous activity in nociceptors after spinal cord injury. Pain 154. 2130-2141, 2013.
78. XIA R, SAMAD TA, BTESH J, JIANG LH, KAYS I, STJERNBORG L, DEKKER N. TRPV1 signaling. mechanistic understanding and therapeutic potential. Curr Top Med Chem 11. 2180-2191, 2011.
79. XU ZZ, ZHANG L, LIU T, PARK JY, BERTA T, YANG R, SERHAN CN, JI RR. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 16. 592-597, 591p following 597, 2010.
80. ZHANG J, CAVANAUGH DJ, NEMENOV MI, BASBAUM AI. The modality-specific contribution of peptidergic and non-peptidergic nociceptors is manifest at the level of dorsal horn nociresponsive neurons. J Physiol 591. 1097-1110, 2013.
81. ZHOU HY, CHEN SR, CHEN H, PAN HL. The glutamatergic nature of TRPV1-expressing neurons in the spinal dorsal horn. J Neurochem 108. 305-318, 2009.
82. ZHOU HY, CHEN SR, CHEN H, PAN HL. Opioid-induced long-term potentiation in the spinal cord is a presynaptic event. J Neurosci 30. 4460-4466, 2010.
83. ZYGMUNT PM, PETERSSON J, ANDERSSON DA, CHUANG H, SORGARD M, DI MARZO V, JULIUS D, HOGESTATT ED. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400. 452-457, 1999.